688 related articles for article (PubMed ID: 18090241)
21. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
[TBL] [Abstract][Full Text] [Related]
22. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.
Schmidt CM; White PB; Waters JA; Yiannoutsos CT; Cummings OW; Baker M; Howard TJ; Zyromski NJ; Nakeeb A; DeWitt JM; Akisik FM; Sherman S; Pitt HA; Lillemoe KD
Ann Surg; 2007 Oct; 246(4):644-51; discussion 651-4. PubMed ID: 17893501
[TBL] [Abstract][Full Text] [Related]
23. Intraductal papillary mucinous neoplasm.
Shi C; Hruban RH
Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
[TBL] [Abstract][Full Text] [Related]
24. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
Yonezawa S; Nakamura A; Horinouchi M; Sato E
J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144
[TBL] [Abstract][Full Text] [Related]
25. Intraductal papillary mucinous neoplasms of the pancreas.
Gourgiotis S; Ridolfini MP; Germanos S
Eur J Surg Oncol; 2007 Aug; 33(6):678-84. PubMed ID: 17207960
[TBL] [Abstract][Full Text] [Related]
26. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N
Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327
[TBL] [Abstract][Full Text] [Related]
27. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas.
Ingkakul T; Sadakari Y; Ienaga J; Satoh N; Takahata S; Tanaka M
Ann Surg; 2010 Jan; 251(1):70-5. PubMed ID: 20009749
[TBL] [Abstract][Full Text] [Related]
28. Comparison between mucinous cystic neoplasm and intraductal papillary mucinous neoplasm of the branch duct type of the pancreas with respect to expression of CD10 and cytokeratin 20.
Nishigami T; Onodera M; Torii I; Sato A; Tao LH; Kushima R; Kakuno A; Kishimoto M; Katsuyama E; Fujimori T; Hirano H; Satake M; Kuroda N; Nishiguchi S; Fujimoto J; Tsujimura T
Pancreas; 2009 Jul; 38(5):558-64. PubMed ID: 19287335
[TBL] [Abstract][Full Text] [Related]
29. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
30. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.
Fan F; Lai EC; Xie F; Yang JM; Xu F; Kan T; Shen RX; Yang XY; Lau Wan Y; Wu MC
Hepatogastroenterology; 2010; 57(99-100):635-9. PubMed ID: 20698241
[TBL] [Abstract][Full Text] [Related]
31. Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms.
Yoon WJ; Ryu JK; Lee JK; Woo SM; Lee SH; Park JK; Kim YT; Yoon YB
Ann Surg Oncol; 2008 Nov; 15(11):3193-8. PubMed ID: 18784959
[TBL] [Abstract][Full Text] [Related]
32. Intraductal papillary mucinous neoplasm: a clinicopathologic review.
Augustin T; Vandermeer TJ
Surg Clin North Am; 2010 Apr; 90(2):377-98. PubMed ID: 20362793
[TBL] [Abstract][Full Text] [Related]
33. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type.
Sadakari Y; Ohuchida K; Nakata K; Ohtsuka T; Aishima S; Takahata S; Nakamura M; Mizumoto K; Tanaka M
Surgery; 2010 Jun; 147(6):812-7. PubMed ID: 20060146
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas.
Fujii T; Kato K; Kodera Y; Kanda M; Nagai S; Yamada S; Kanzaki A; Sugimoto H; Nomoto S; Takeda S; Morita S; Nakamura S; Nakao A
Surgery; 2010 Aug; 148(2):285-90. PubMed ID: 20434746
[TBL] [Abstract][Full Text] [Related]
35. CD44v6 expression in intraductal papillary mucinous neoplasms of the pancreas.
Miyasaka Y; Nagai E; Ohuchida K; Nakata K; Hayashi A; Mizumoto K; Tsuneyoshi M; Tanaka M
Pancreas; 2010 Jan; 39(1):31-5. PubMed ID: 19952968
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of clinical meaning of histological subtypes of intraductal papillary mucinous neoplasm of the pancreas.
Kang MJ; Lee KB; Jang JY; Han IW; Kim SW
Pancreas; 2013 Aug; 42(6):959-66. PubMed ID: 23462330
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy.
Yamaguchi T; Shirai Y; Ishihara T; Sudo K; Nakagawa A; Ito H; Miyazaki M; Nomura F; Saisho H
Cancer; 2005 Dec; 104(12):2830-6. PubMed ID: 16287152
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic features of re-resected cases of intraductal papillary mucinous neoplasms (IPMNs).
Yokoyama Y; Nagino M; Oda K; Nishio H; Ebata T; Abe T; Igami T; Nimura Y
Surgery; 2007 Aug; 142(2):136-42. PubMed ID: 17689677
[TBL] [Abstract][Full Text] [Related]
39. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
[TBL] [Abstract][Full Text] [Related]
40. Frequency of subtypes of biliary intraductal papillary mucinous neoplasm and their MUC1, MUC2, and DPC4 expression patterns differ from pancreatic intraductal papillary mucinous neoplasm.
Sclabas GM; Barton JG; Smyrk TC; Barrett DA; Khan S; Kendrick ML; Reid-Lombardo KM; Donohue JH; Nagorney DM; Que FG
J Am Coll Surg; 2012 Jan; 214(1):27-32. PubMed ID: 22112419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
